Multiple Sclerosis Clinical Trial
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Summary
The objectives of the study are to evaluate the safety, tolerability, and efficacy of 3 doses of AVP-923 capsules in the treatment of central neuropathic pain in participants with multiple sclerosis.
Full Description
The objectives of the study are to evaluate the safety, tolerability, and efficacy of 3 doses of AVP-923 (dextromethorphan [DM]/quinidine [Q]) capsules containing either 45 mg DM and 10 mg Q (AVP-923-45) or 30 mg DM and 10 mg Q (AVP-923-30) or 20 mg DM and 10 mg Q (AVP-923-20) compared to placebo, for the treatment of central neuropathic pain in a population of participants with multiple sclerosis (MS) over a 12-week period. The MS participant population enrolled includes participants with relapsing-remitting multiple sclerosis (RRMS) and participants with secondary progressive multiple sclerosis (SPMS).
Eligibility Criteria
Main Inclusion Criteria:
Multiple Sclerosis (relapsing-remitting multiple sclerosis [RRMS] or secondary progressive multiple sclerosis [SPMS]), Clinical history and symptoms of central neuropathic pain (dysesthetic pain) for at least 3 months prior to screening, pain rating scale (PRS) baseline score = or > 4, No MS relapse within previous 30 days.
Main Exclusion Criteria:
Personal history of complete heart block, QT interval corrected for heart rate (QTc) prolongation, or torsades de pointes, family history of congenital QT interval prolongation syndrome, Myasthenia Gravis, Beck Depression Inventory Second Edition (BDI-II) score > 19
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 68 Locations for this study
Cullman Alabama, 35058, United States
Phoenix Arizona, 85013, United States
Berkeley California, 94705, United States
Orange California, 92868, United States
San Diego California, 92103, United States
San Francisco California, 94158, United States
Aurora Colorado, 80045, United States
Maitland Florida, 32751, United States
Naples Florida, 34102, United States
North Palm Beach Florida, 33408, United States
Ormond Beach Florida, 32174, United States
Pompano Beach Florida, 33060, United States
Ponte Vedra Beach Florida, 32082, United States
Saint Petersburg Florida, 33713, United States
Tampa Florida, 33612, United States
Vero Beach Florida, 32960, United States
Atlanta Georgia, 30309, United States
Chicago Illinois, 60612, United States
Northbrook Illinois, 60062, United States
Indianapolis Indiana, 46256, United States
Lenexa Kansas, 66214, United States
Baltimore Maryland, 21287, United States
Boston Massachusetts, 02215, United States
Clinton Township Michigan, 48035, United States
Detroit Michigan, 48201, United States
Detroit Michigan, 48202, United States
Great Falls Montana, 59405, United States
Lincoln Nebraska, 68506, United States
Albany New York, 12208, United States
New York New York, 10003, United States
Rochester New York, 14642, United States
Stony Brook New York, 11794, United States
Charlotte North Carolina, 28207, United States
Cleveland Ohio, 44195, United States
Oklahoma City Oklahoma, 73104, United States
Philadelphia Pennsylvania, 19107, United States
Wilkes-Barre Pennsylvania, 18711, United States
Franklin Tennessee, 37064, United States
Houston Texas, 77030, United States
Salt Lake City Utah, 84103, United States
Henrico Virginia, 23226, United States
Vienna Virginia, 22182, United States
Seattle Washington, 98122, United States
Tacoma Washington, 98405, United States
Ciudad Autonoma de Buenos Aires Buenos Aires, C1126, Argentina
Ciudad Autonoma de Buenos Aires Buenos Aires, C1280, Argentina
Ciudad Autónoma de Buenos Aires Buenos Aires, C1181, Argentina
Ciudad de Buenos Aires Buenos Aires, C1015, Argentina
Buenos Aires , C1437, Argentina
Buenos Aires , CP111, Argentina
Ciudad Autonoma de Buenos Aires , , Argentina
Santa Fe , , Argentina
Brno , , Czechia
Hradec Kralove , 500 0, Czechia
Jihlava , 586 3, Czechia
Ostrava , 708 5, Czechia
Praha 2 , 128 2, Czechia
Czeladz , 41-25, Poland
Gdansk , 80-80, Poland
Katowice , 40-59, Poland
Katowice , 40-75, Poland
Katowice , , Poland
Konskie , 26-20, Poland
Plewiska , 62-06, Poland
Poznan , 61-28, Poland
Szczecin , 70-21, Poland
Barcelona Cataluña, 08003, Spain
Barcelona Cataluña, 08035, Spain
Girona Cataluña, 17007, Spain
El Palmar Murcia, 30120, Spain
Santa Cruz De Tenerife , 38010, Spain
Sevilla , 41009, Spain
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.